Comparison of high-flow nasal cannula versus oxygen face mask for environmental bacterial contamination in critically ill pneumonia patients : a randomized controlled crossover trial
Copyright © 2018 The Author(s). Published by Elsevier Ltd.. All rights reserved..
Whereas high-flow nasal cannula use is gaining prevalence, its high gas flow raises concerns about aerosolization of infectious particles and spread of infection. This randomized controlled crossover non-inferiority trial (N = 20) evaluated the degree of environmental contamination by viable bacteria associated with the use of high-flow nasal cannula compared with conventional oxygen mask for critically ill patients with Gram-negative pneumonia. The results show that high-flow nasal cannula use was not associated with increased air or contact surface contamination by either Gram-negative bacteria or total bacteria, suggesting that additional infection control measures are not required.
| Errataetall: |
CommentIn: Eur Respir J. 2020 May 14;55(5):. - PMID 32299867 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:101 |
|---|---|
| Enthalten in: |
The Journal of hospital infection - 101(2019), 1 vom: 10. Jan., Seite 84-87 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Leung, C C H [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Bacterial pneumonia |
|---|
| Anmerkungen: |
Date Completed 04.02.2019 Date Revised 15.02.2019 published: Print-Electronic CommentIn: Eur Respir J. 2020 May 14;55(5):. - PMID 32299867 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jhin.2018.10.007 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM289706971 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM289706971 | ||
| 003 | DE-627 | ||
| 005 | 20231225063136.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jhin.2018.10.007 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0965.xml |
| 035 | |a (DE-627)NLM289706971 | ||
| 035 | |a (NLM)30336170 | ||
| 035 | |a (PII)S0195-6701(18)30542-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Leung, C C H |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Comparison of high-flow nasal cannula versus oxygen face mask for environmental bacterial contamination in critically ill pneumonia patients |b a randomized controlled crossover trial |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.02.2019 | ||
| 500 | |a Date Revised 15.02.2019 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Eur Respir J. 2020 May 14;55(5):. - PMID 32299867 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2018 The Author(s). Published by Elsevier Ltd.. All rights reserved. | ||
| 520 | |a Whereas high-flow nasal cannula use is gaining prevalence, its high gas flow raises concerns about aerosolization of infectious particles and spread of infection. This randomized controlled crossover non-inferiority trial (N = 20) evaluated the degree of environmental contamination by viable bacteria associated with the use of high-flow nasal cannula compared with conventional oxygen mask for critically ill patients with Gram-negative pneumonia. The results show that high-flow nasal cannula use was not associated with increased air or contact surface contamination by either Gram-negative bacteria or total bacteria, suggesting that additional infection control measures are not required | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Randomized Controlled Trial | |
| 650 | 4 | |a Bacterial pneumonia | |
| 650 | 4 | |a Environmental contamination | |
| 650 | 4 | |a Infection control | |
| 650 | 4 | |a Infectious disease transmission | |
| 650 | 4 | |a Oxygen therapy | |
| 700 | 1 | |a Joynt, G M |e verfasserin |4 aut | |
| 700 | 1 | |a Gomersall, C D |e verfasserin |4 aut | |
| 700 | 1 | |a Wong, W T |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, A |e verfasserin |4 aut | |
| 700 | 1 | |a Ling, L |e verfasserin |4 aut | |
| 700 | 1 | |a Chan, P K S |e verfasserin |4 aut | |
| 700 | 1 | |a Lui, P C W |e verfasserin |4 aut | |
| 700 | 1 | |a Tsoi, P C Y |e verfasserin |4 aut | |
| 700 | 1 | |a Ling, C M |e verfasserin |4 aut | |
| 700 | 1 | |a Hui, M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of hospital infection |d 1993 |g 101(2019), 1 vom: 10. Jan., Seite 84-87 |w (DE-627)NLM012638692 |x 1532-2939 |7 nnns |
| 773 | 1 | 8 | |g volume:101 |g year:2019 |g number:1 |g day:10 |g month:01 |g pages:84-87 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jhin.2018.10.007 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 101 |j 2019 |e 1 |b 10 |c 01 |h 84-87 | ||